Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCancer: New RAF inhibitor with broad activity.AuthorsCrunkhorn, SarahAbstractThe article discusses findings of a study which confirms the greater efficacy of the BGB659 type II ATP-competitive RAF enzyme inhibitor in reducing cancer growth in mice compared to vemurafenib which can only inhibit mutant monomers.SubjectsDRUG efficacy; ENZYME inhibitors; TUMOR growth; GENETIC mutation; MONOMERSPublicationNature Reviews Drug Discovery, 2015, Vol 14, Issue 11, p750ISSN1474-1776Publication typejournal articleDOI10.1038/nrd4778